Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) important roles in the oncogenesis and progression of gliomas including
high-grade gliomas. However
was established for 66.67 % of the workers; moderate, 9.2 %;
high, 23.81 %. We assessed rhinocytograms
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) received tocilizumab, baricitinib,
high doses of dexamethasone, or standard therapy. Results
Bogdanov, A,
Tsivileva, O,
Voloshina, A,
Lyubina, A,
Amerhanova, S,
Burtceva, E,
Bukharov, S,
Samorodov, A,
Pavlov, V (2022) -resistant Staphylococcus aureus strains. The study also showed low hemo-and cytotoxicity (Chang Liver) and
highTalybov, Rustam,
Beylerli, Ozal,
Mochalov, Vadim,
Prokopenko, Alexey,
Ilyasova, Tatiana,
Trofimova, Tatiana,
Sufianov, Albert,
Guang, Yang (2022) in the differential diagnosis of primary lymphomas of the central nervous system in comparison with
highly malignant
Ksenofontov, Alexander A.,
Bocharov, Pavel S.,
Antina, Elena V.,
Shevchenko, Oksana G.,
Samorodov, Aleksandr V.,
Gilfanov, Ilmir R.,
Pavelyev, Roman S.,
Ostolopovskaya, Olga V.,
Startseva, Valeriya A.,
Fedyunina, Inna V.,
Azizova, Zulfiya R.,
Gaysin, Salavat I. (2022) for the design and production of new biologically active compounds with
high antioxidant, antimicrobial and anti